跳至主要内容
临床试验/NL-OMON54704
NL-OMON54704招募中不适用

Investigating red blood cell deformability of sickle cell patients who started therapy. - Sicklecellscreen

niversitair Medisch Centrum Utrecht0 个研究点目标入组 344 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
344

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
0 至 64(—)

入选标准

  • No blood transfusion within the past 2 months (only in case of hydrea therapy
  • and newborns)
  • Diagnosed with sickle cell disease by electrophoresis or HPLC.
  • Starting with Hydrea therapy or getting blood transfusion or HSCT or gene
  • therapy, or newborn with SCD, or in steady state with treatment or without
  • treatment. When included in baseline cohort: no treatment, or on chronic blood
  • transfusion or steady state under hydroxyurea.
  • Adults patients or parents/legal guardians (and child depending on age) must
  • give informed consent

排除标准

  • Blood transfusion within past 2 months (not a criteria in patients who are
  • treated with blood transfusion)
  • Body weight below 10 kg (not a criteria in newborns)
  • Age <1 year (not a criteria in newborns)

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验